Your browser doesn't support javascript.
loading
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program.
Aparicio, Thomas; Cozic, Nathalie; de la Fouchardière, Christelle; Meriaux, Emeline; Plaza, Jérome; Mineur, Laurent; Guimbaud, Rosine; Samalin, Emmanuelle; Mary, Florence; Lecomte, Thierry; Gomez-Roca, Carlos; Haineaux, Paul-Arthur; Gratet, Alain; Selves, Jannick; Menu, Yves; Colignon, Nikias; Johnson, Laetitia; Legrand, Frédéric; Vassal, Gilles.
Afiliação
  • Aparicio T; Gastroenterology and Digestive Oncology Department, Hôpital Saint Louis, APHP, Université de Paris, 1 Avenue Claude Vellefaux, 75010, Paris, France. thomas.aparicio@aphp.fr.
  • Cozic N; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • de la Fouchardière C; Oncostat U1018, Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Villejuif, France.
  • Meriaux E; Medical Oncology Department, Centre Léon Bérard, Lyon, France.
  • Plaza J; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, 69373, Lyon, France.
  • Mineur L; Institut du Cancer de l'Ouest-Centre René Gauducheau, Saint Herblain, France.
  • Guimbaud R; Hopitaux Privés de Metz-Hôpital Belle Isle, Metz, France.
  • Samalin E; Institut du cancer Sainte-Catherine Avignon Provence, Avignon, France.
  • Mary F; Universitary Hospital of Toulouse, Toulouse, France.
  • Lecomte T; Medical Oncology Department, Institut du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
  • Gomez-Roca C; Gastroenterology and Digestive Oncology, Hôpital Avicenne, AP-HP, Bobigny, France.
  • Haineaux PA; Gastroenterology and Digestive Oncology, Tours University Hospital, UMR INSERM 1069, Université de Tours, Tours, France.
  • Gratet A; Institut Claudius Regaud, Toulouse, France.
  • Selves J; IUCT-Oncopole, Toulouse, France.
  • Menu Y; Department of Medical Oncology, Poitiers University Hospital, Poitiers, France.
  • Colignon N; Clinique Pasteur, Toulouse, France.
  • Johnson L; IUCT-Oncopole, Toulouse, France.
  • Legrand F; Hôpital Saint Antoine, APHP, Paris, France.
  • Vassal G; Hôpital Saint Antoine, APHP, Paris, France.
Target Oncol ; 16(3): 381-388, 2021 05.
Article em En | MEDLINE | ID: mdl-33847874
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Inibidores de Proteínas Quinases / Crizotinibe Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Inibidores de Proteínas Quinases / Crizotinibe Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França